4//SEC Filing
Arbutus Biopharma Corp 4
Accession 0001140361-16-070360
$ABUSCIK 0001447028operating
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 8:33 PM ET
Size
7.3 KB
Accession
0001140361-16-070360
Insider Transaction Report
Form 4
Murray Mark J.
DirectorPresident & CEO
Transactions
- Exercise of In-Money
Common Shares
2016-06-16$2.57/sh+5,000$12,844→ 289,389 total - Exercise of In-Money
Warrants
2016-06-16−5,000→ 0 totalExercise: $2.57From: 2011-06-16Exp: 2016-06-16→ Common shares (5,000 underlying)
Footnotes (2)
- [F1]Exercise price of Cdn$3.35 converted into U.S. dollars using the noon Bank of Canada exchange rate on June 16, 2016 of Cdn$1.3041=US$1.00.
- [F2]The warrants were purchased as part of a private placement unit offering for Cdn$2.85 per unit, each unit consisting of one common shares and one-half of one common share purchase warrant exercisable at Cdn$3.35 for five years.
Documents
Issuer
Arbutus Biopharma Corp
CIK 0001447028
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001447028
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 8:33 PM ET
- Size
- 7.3 KB